Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study

npj Parkinson's Disease

Volumn 2, Issue 1, 2016, Pages

  Wood, Kyla Louise ^a,b   Myall, Daniel J ^b   Livingston, Leslie ^b,c   Melzer, Tracy R ^b,c,d   Pitcher, Toni L ^b,c   MacAskill, Michael R ^b,c   Geurtsen, Gert J ^e   Anderson, Tim J ^b,c,d,f   Dalrymple Alford, John C ^a,b,c,d  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b NEW ZEALAND BRAIN RESEARCH INSTITUTE   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d Universities of Auckland and Otago   (New Zealand)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85014820814     PISSN: None     EISSN: 23738057     Source Type: Journal    
DOI: 10.1038/npjparkd.2015.27     Document Type: Article

References (46)

1. Oosterveld, L. P. et al. Prognostic factors for early mortality in Parkinson's disease. Parkinsonism Relat. Disord. 21, 226–230 (2015).
2. Lawson, R. A. et al. Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life. Parkinsonism Relat. Disord. 20, 1071–1075 (2014).
3. Hely, M. A., Reid, W., Adena, M., Halliday, G. M. & Morris, J. G. L. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov. Disord. 23, 837–844 (2008).
4. Buter, T. C. et al. Dementia and survival in Parkinson disease: a 12-year population study. Neurology 70, 1017–1022 (2008).
5. Aarsland, D., Anderson, K., Larsen, J. P., Lolk, A. & Kragh-Sørensen, P. Prevalence and characteristics of dementia in Parkinson’s disease: an 8-year prospective study. Arch. Neurol. 60, 387–392 (2003).
6. Aarsland, D. & Kurz, M. W. Epidemiology of dementia associated with Parkinson’s disease. Brain Pathol. 20, 633–639 (2010).
7. Aarsland, D., Bronnick, K. & Fladby, T. Mild cognitive impairment in Parkinson's disease. Curr. Neurol. Neurosci. Rep. 11, 371–378 (2011).
8. Yarnall, A. J., Rochester, L. & Burn, D. J. Mild cognitive impairment in Parkinson’s disease. Age Ageing 42, 567–576 (2013).
9. Palavara N. C., Naismith S. L., Lewis S. J. G. Mild cognitive impairment in Parkinson’s disease: a review of current concepts. Neurol. Res. Int. 2013; 2013: 576091.
10. Tröster, A. I. A précis of recent advances in the neuropsychology of mild cognitive impairment(s) in Parkinson’s disease and a proposal of preliminary research criteria. J. Int. Neuropsychol. Soc. 17, 1–14 (2011).
11. Janvin, C. C., Larsen, J. P., Aarsland, D. & sHugdahl, K. Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov. Disord. 21, 1343–1349 (2006).
12. Pedersen, K. F., Larsen, J. P., Tysnes, O. & Alves, G. Prognosis of mild cognitive impairment in early Parkinson’s disease. JAMA Neurol. 70, 580–586 (2013).
13. Broeders, M., de Bie, R. M. A., Velselboar, D. C., Muslimovic, D. & Schmand, B. Evolution of mild cognitive impairment in Parkinson disease. Neurology 81, 346–352 (2013).
14. Hobson, P. & Meara, J. Mild cognitive impairment in Parkinson’s disease and its progression on to dementia: a 16-year outcome evaluation of the Denbighshire cohort. Int. J. Geriatr. Psychiatry 30, 1048–1055 (2015).
15. Aarsland, D. et al. Mild cognitive impairment in Parkinson’s disease. Neurology 75, 1062–1069 (2010).
16. Dalrymple-Alford, J. C. et al. Characterising mild cognitive impairment in Parkinson’s disease. Mov. Disord. 26, 629–636 (2011).
17. Liepelt-Scarfone I. et al. Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson’s disease. Parkinsons Dis. 2011; 2011: 540843.
18. Goldman, J. G. et al. Defining optimal cutoff scores for cognitive impairment using Movement Disorders Society criteria for mild cognitive impairment in Parkinson’s disease. Mov. Disord. 28, 1972–1979 (2013).
19. Litvan, I. et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines. Mov. Disord. 28, 1972–1979 (2012).
20. Eberling, J. et al. Therapeutic development paths for cognitive impairment in Parkinson’s disease: report of a regulatory roundtable. J. Parkinsons Dis. 4, 585–589 (2014).
21. Jak, A. J. et al. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am. J. Geriatr. Psychiatry 17, 368–375 (2009).
22. Teng, E., Tingus, K. D., Lu, P. H. & Cummings, J. L. Persistence of neuropsychological testing deficits in mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 28, 168–178 (2009).
23. Beach, T. G. et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 117, 613–634 (2009).
24. Jellinger, K. A. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov. Disord. 27, 8–30 (2012).
25. Melzer, T. R. et al. Arterial spin labeling reveals an abnormal cerebral perfusion pattern in Parkinson’s disease. Brain 134, 845–855 (2011).
26. Melzer, T. et al. White matter microstructure deteriorates across cognitive stages in Parkinson’s disease. Neurology 80, 1841–1849 (2013).
27. Goldman, J. G. et al. Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests? Mov. Disord. 30, 402–406 (2015).
28. Hindle J. V. et al. The effects of cognitive reserve and lifestyle on cognition and dementia in Parkinson’s disease—a longitudinal cohort study. Int. J. Geriatr. Psychiatry; e-pub ahead of print 17 March 2015.
29. Sebastiani, P. et al. Meta-analysis of genetic variants associated with human exceptional longevity. Aging 5, 653–661 (2013).
30. Barker, R. A. & Williams-Gray, C. H. Mild cognitive impairment and Parkinson’s disease—something to remember. J. Parkinsons Dis. 4, 651–656 (2014).
31. Anang, J. B. M. et al. Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology 83, 1254–1260 (2014).
32. Irwin, D. J., Lee, V. M. Y. & Trojanowski, J. Q. Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. Nat. Rev. Neurosci. 14, 626–636 (2013).
33. Marras, C. et al. Measuring mild cognitive impairment in patients with Parkinson’s disease. Mov. Disord. 28, 626–633 (2013).
34. Mahieux, F. et al. Neuropsychological prediction of dementia in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 64, 178–183 (1998).
35. Jacobs, D. M. et al. Neuropsychological characteristics of preclinical dementia in Parkinson’s disease. Neurology 45, 1691–1691 (1995).
36. Woods, S. P. & Tröster, A. L. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson’s disease. J. Int. Neuropsychol. Soc. 9, 17–24 (2003).
37. Geurtsen, G. J. et al. Parkinson’s disease mild cognitive impairment: application and validation of the criteria. J. Parkinsons Dis. 4, 131–137 (2014).
38. Lezak M. D., Howieson D. B., Bigler E. D., Tranel D. Neuropsychological Assessment 5th (edition). Oxford Univ. Press, 2012.
39. Bossuyt, P. M. et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann. Intern. Med. 138, 40–44 (2003).
40. Emre, M. et al. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov. Disord. 22, 1689–1707 (2007).
41. Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181–184 (1992).
42. Reisberg, B. et al. Mild cognitive impairment: a historical perspective. Int. Psychogeriatr. 20, 18–31 (2008).
43. Morris, J. C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43: 2412–2414 (1993).
44. Strauss E., Sherman E. M. S., Spreen O. A Compendium of Neuropsychological Tests 3rd (edition). Oxford Univ. Press, 2006.
45. Delis D. C., Kaplan E., Kramer J. Delis-Kaplan Executive Function System (Psychological Corporation, 2001a).
46. Efron, B. Bootstrap methods: another look at the jackknife. Ann. Stat. 7, 1–26 (1979).